AARTIDRUGSNSEAarti Drugs Limited· PharmaceuticalsLowNeutral
Announced Thu, 21 Aug · 16:27 IST

Aarti Drugs Limited has informed the Exchange regarding a press release dated August 21, 2025, titled "100 days Campaign Saksham Niveshak".

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aarti Drugs has informed the stock exchanges that it is participating in the 'Saksham Niveshak' 100-day campaign launched by the Investor Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs. The campaign runs from July 28, 2025 to November 6, 2025 and aims to help shareholders update their KYC details — such as PAN, bank account, nomination, address and signature — with the Registrar & Share Transfer Agent, MUFG Intime India Private Limited. Shareholders with unpaid or unclaimed dividends are urged to claim them before they get transferred to the IEPF. The company has reminded investors that any dividend unclaimed for seven consecutive years, along with the underlying shares, will be moved to the IEPF. Forms ISR-1, ISR-2, SH-13 and ISR-3 can be submitted by post, email or via MUFG's online portal, with a deadline of November 6, 2025.

Likely market impact

This is a routine compliance and shareholder-awareness communication with no impact on the company's financials or stock price. Shareholders who have unclaimed dividends or outdated KYC details should act before November 6, 2025 to avoid losing the money or shares to the IEPF.